Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-03

Clinical Trial Update: Primary Prevention of Stroke in Children With SCD in Sub-Saharan Africa II [Phase 3]

View source ↗

Summary

Phase 3 trial updating primary prevention of stroke in children with sickle cell disease in Sub-Saharan Africa has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: Sickle Cell Disease, Stroke | Phase 3 | Status: COMPLETED